Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure
Abstract ST2 is a member of the interleukin-1 receptor family biomarker and circulating soluble ST2 concentrations are believed to reflect cardiovascular stress and fibrosis. Recent studies have demonstrated soluble ST2 to be a strong predictor of cardiovascular outcomes in both chronic and acute he...
Main Authors: | Humberto Villacorta, Alan S. Maisel |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Cardiologia (SBC)
2016-01-01
|
Series: | Arquivos Brasileiros de Cardiologia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2016005002102&lng=en&tlng=en |
Similar Items
-
Acute Heart Failure Registry: Risk Assessment Model in Decompensated Heart Failure
by: Anne Delgado, et al. -
Biomarkers in Heart Failure
by: Pedro Pimenta de Mello Spineti -
Reverse Cardiac Remodeling: A Marker of Better Prognosis in Heart Failure
by: José Rosino de Araújo Rocha Reis Filho, et al.
Published: (2015-06-01) -
Galectin-3: A Link between Myocardial and Arterial Stiffening in Patients with Acute Decompensated Heart Failure?
by: Radu Ioan Lala, et al.
Published: (2016-01-01) -
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
by: Michael Coll Barroso, et al.
Published: (2017-09-01)